10:38:30 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-12 Bokslutskommuniké 2024
2024-11-06 Kvartalsrapport 2024-Q3
2024-08-23 Kvartalsrapport 2024-Q2
2024-06-14 Bokslutskommuniké 2023
2024-06-07 Årsstämma 2024
2024-05-15 Kvartalsrapport 2024-Q1
2023-08-24 Kvartalsrapport 2023-Q2
2023-06-12 Ordinarie utdelning ABTEC 0.00 NOK
2023-06-09 Årsstämma 2023
2023-04-28 Bokslutskommuniké 2022
2022-08-24 Kvartalsrapport 2022-Q2
2022-06-10 Ordinarie utdelning ABTEC 0.00 NOK
2022-06-09 Årsstämma 2022
2022-04-29 Bokslutskommuniké 2021
2021-08-25 Kvartalsrapport 2021-Q2
2021-06-10 Ordinarie utdelning ABTEC 0.00 NOK
2021-06-09 Årsstämma 2021
2021-04-30 Bokslutskommuniké 2020
2020-09-11 Extra Bolagsstämma 2020
2020-08-26 Kvartalsrapport 2020-Q2
2020-06-11 Ordinarie utdelning ABTEC 0.00 NOK
2020-06-10 Årsstämma 2020
2020-04-15 Bokslutskommuniké 2019
2019-08-28 Kvartalsrapport 2019-Q2
2019-06-06 Ordinarie utdelning ABTEC 0.00 NOK
2019-06-05 Årsstämma 2019
2019-04-24 Bokslutskommuniké 2018
2019-01-07 Extra Bolagsstämma 2019
2018-08-22 Kvartalsrapport 2018-Q2
2018-05-30 Årsstämma 2018
2018-02-21 Bokslutskommuniké 2017
2017-08-16 Kvartalsrapport 2017-Q2
2017-06-08 Ordinarie utdelning ABTEC 1.00 NOK
2017-06-07 Årsstämma 2017
2017-02-15 Bokslutskommuniké 2016
2016-11-18 Bonusutdelning ABTEC 1
2016-11-17 Extra Bolagsstämma 2016
2016-11-17 Kvartalsrapport 2016-Q3
2016-08-17 Kvartalsrapport 2016-Q2
2016-06-09 Ordinarie utdelning ABTEC 1.50 NOK
2016-06-08 Årsstämma 2016
2016-05-11 Kvartalsrapport 2016-Q1
2016-02-10 Bokslutskommuniké 2015
2015-11-18 Kvartalsrapport 2015-Q3
2015-08-19 Kvartalsrapport 2015-Q2
2015-06-04 Ordinarie utdelning ABTEC 1.00 NOK
2015-06-03 Årsstämma 2015
2015-05-13 Kvartalsrapport 2015-Q1
2015-02-11 Bokslutskommuniké 2014
2014-11-26 Kvartalsrapport 2014-Q3
2014-08-20 Kvartalsrapport 2014-Q2
2014-06-11 Årsstämma 2014
2014-05-21 Kvartalsrapport 2014-Q1
2014-02-12 Bokslutskommuniké 2013
2013-11-27 Kvartalsrapport 2013-Q3
2013-08-21 Kvartalsrapport 2013-Q2
2013-06-13 Kapitalmarknadsdag 2013
2013-06-12 Ordinarie utdelning
2013-06-11 Årsstämma 2013
2013-05-22 Kvartalsrapport 2013-Q1
2013-02-13 Bokslutskommuniké 2012
2012-11-27 Kvartalsrapport 2012-Q3
2012-08-28 Kvartalsrapport 2012-Q2
2012-06-14 Årsstämma 2012
2012-05-23 Kvartalsrapport 2012-Q1
2012-02-17 Bokslutskommuniké 2011
2011-11-30 Kvartalsrapport 2011-Q3
2011-08-29 Kvartalsrapport 2011-Q2
2011-06-17 Ordinarie utdelning
2011-06-16 Årsstämma 2011
2011-05-30 Kvartalsrapport 2011-Q1
2011-02-18 Bokslutskommuniké 2010

Beskrivning

LandNorge
ListaOAX Equities
SektorHälsovård
IndustriBioteknik
Aqua Bio Technology är ett norskt bolag verksamma inom kosmetikabranschen. Bolaget utvecklar, tillverkar och kommersialiserar ingredienser som används inom ett flertal kosmetiska produkter världen över. Störst verksamhet återfinns inom lösningar för hudvårdsprodukter. Merparten av bolagets produkter säljs på en global marknad via diverse distributörer. Bolaget grundades 2004 och har sitt huvudkontor i Lysaker.
2023-12-19 13:34:37

19.12.2023 13:34:34 CET | Aqua Bio Technology ASA | Inside information

Aqua Bio Technology ("ABT" or the "Company" and together with its wholly owned subsidiaries, the "ABT Group") has today, on 19 December 2023, entered into a share purchase agreement ("Share Purchase Agreement") with Medvind Holding AS ("Medvind") for the Company's acquisition of all the outstanding shares in the Norwegian company Cover Brands AS ("Coverbrands") for a purchase price of NOK 16.5 million. The purchase price will be settled through the Company issuing 6,000,000 consideration shares at a subscription price of NOK 2.75 per consideration share (the "Consideration Shares"). Medvind and its ultimate owners have signed a lock-up undertaking for a period of 36 months with respect to the Consideration Shares.

Concurrently, Jesper Dønnestad Brandt and an associated investor will each subscribe for ABT shares for NOK 2.5 million at the same subscription price (the "Investment Shares" and jointly with the Consideration Shares, the "New Shares"). The NOK 5 million capital raised will be used to strengthen Coverbrands' equity and access to credit lines.

Consummation of the acquisition of Coverbrands is expected to occur no later than 22 December 2023. The New Shares will be issued pursuant to a board authorization registered in the Norwegian Registry for Business Enterprises on 29 September 2023.

Coverbrands started as an e-commerce business, selling beauty products to customer through the company's web shop and has today an e-commerce platform with over 140,000 customers. Through social media and influencers, Cover Brands has a combined reach of ~2 million users. Coverbrands has today become a well-known brand in the cosmetic market, with a diverse range of product offerings catering to a broad audience.  In addition to the e-commerce business, Coverbrands has successfully established B2B distribution channels to several retail channels in Norway and Sweden

Coverbrands has also recently opened a flagship store in central Kristiansand, where they share space with Pusterom Hudpleie AS ("Pusterom"), offering a comprehensive beauty experience to consumers with products offerings and treatments, with the daily management overseen by the CEO of Pusterom. The ultimate owners of Coverbrands are major stakeholders in Pusterom through Ovalen AS ("Ovalen"), alongside Jesper Dønnestad Brandt who co-founded the store chain Normal Norge AS ("Normal Norge").

With this agreement, ABT and Coverbrands will secure the entire value chain from production to the end users. The acquisition of Coverbrands coincides with ABT's adopted strategy of securing larger distributors. Previously, ABT bought Cosmed Beauty AS ("Cosmed Beauty "), Ultrabody AB ("Ultrabody") and Skinteam Norge AS ("Skinteam"). Through the acquisition of Coverbrands, ABT will have one of the largest distributions towards B2B and B2C in the Nordics, where both Cosmed Beauty, Ultrabody and Coverbrands will act as solid supporters of the Skinteam model. 

With Coverbrands' large revenue there are good opportunities to improve margins and profitability for the ABT Group's business model. Coverbrands revenue was above NOK 100 million in both 2021 and 2022 and is expected to surpass NOK 80 million in 2023. ABT expects that the acquisition of Coverbrands will provide the ABT Group with significant synergies and benefits, including:

  • Coverbrand will, together with Cosmed Beauty and Ultrabody, act as solid supporters of the Skinteam business model, recruiting both new membership stores and customers. 

 

  • Cosmed Beauty's demonstrated e-commerce expertise applied on Coverbrands' large customer base is expected to yield significant synergies and further growth.

 

  • Coverbrands' presence in the Swedish market will facilitate market presence and access for Skinteam and Ultrabody.

 

  • Based on the successful model of Normal Norge, the ultimate owners of Coverbrands and Jesper Dønnestad Brandt intend to establish new flagship stores in Oslo, Bergen and Trondheim, where ABT will serve as a product supplier to both Pusterom and such stores. ABT will be given an option to acquire Ovalen.

 

  • 3D Innovation Nordic AS has the same ownership as Pusterom and is a wholesale company that is expected to benefit from having the ABT Group as a products and private label supplier, providing growth and synergies.

                                               

  • Coverbrands will be the main sponsor of Palmesus (https://www.palmesus.com/) which has high visibility and engagement in the relevant market and Coverbrands expects to be able to leverage ABT's and Skinteam's business models during the festival.

ABT sees the acquisition of Coverbrands is a significant step in its communicated consolidation strategy. Based on ABT's research, the Norwegian beauty industry, with a cumulative turnover of close to NOK 22 billion, presents a fragmented landscape where ABT sees potential for further market consolidation and growth.

For any additional information, please visit:

The Company has considered the issuance of the New Shares in light of the equal treatment obligations under the Norwegian Securities Trading Act and the Oslo Rule Book II, and notes that the issuance of the New Shares implies a deviation from the pre-emptive rights of the Company's shareholders to subscribe for new shares. The Board is of the view that the issuance of the New Shares complies with the requirements for equal treatment, and that the deviation from the pre-emptive rights is justifiable as the Consideration Shares are issued as settlement for the acquisition of Coverbrands, and the net proceeds from the Investment Shares enables the Company to increase Coverbrands equity and access to credit lines, with the price per New Share set at a premium compared to the latest closing price of the Company's shares, on Monday, 18 December 2023, which was NOK 2,52.

 

****

For further information, please contact CEO Håvard Lindstrøm mobile phone +47 941 32 288.

Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skincare products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skincare products developed by partners towards consumers and professional users. ABT's focus on commercialization and development of natural ingredients and natural skincare products has been, and will continue to be, an important part of the Company's strategy going forward. Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock Exchange.

This information is considered to be inside information pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. This stock exchange notice was published by CEO Håvard Lindstrøm on the date and time provided.

 

Disclosure regulation

This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.

Contacts

About Aqua Bio Technology ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

Attachments